ArticleInternational immunopharmacology2024

Chemokine CXCL13 facilitates anti-FVIII inhibitory antibody development in hemophilia A patients and murine models.

Liping Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.